Language

Medicine shortages: Belgium · Page 28

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 28 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 28

Belgium

Ganirelix Gedeon Richter 0.25 mg/0.5 ml inj. opl. s.c. voorgev. spuit 6 x 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Ganirelix

Notice details →
Belgium

Hukyndra 40 mg (Orifarm) inj. opl. s.c. voorgev. pen 2 x 0.4 ml

Nicht verfügbar · Sonstige
Active ingredient: Adalimumab

Notice details →
Belgium

Hukyndra 40 mg (Orifarm) inj. opl. s.c. voorgev. pen 6 x 0.4 ml

Nicht verfügbar · Sonstige
Active ingredient: Adalimumab

Notice details →
Belgium

Levorichter 30 0.03 mg - 0.15 mg omh. tabl. 13 x 21

Nicht verfügbar · Logistics issues (transport, customs, etc.)
Active ingredient: Ethinylestradiol; Levonorgestrel

Notice details →
Belgium

Lindynette 30 75 µg - 30 µg omh. tabl. 13 x 21

Available again · Logistics issues (transport, customs, etc.)
Active ingredient: Ethinylestradiol; Gestodene

Notice details →
Belgium

Lindynette 30 75 µg - 30 µg omh. tabl. 6 x 21

Nicht verfügbar · Logistics issues (transport, customs, etc.)
Active ingredient: Ethinylestradiol; Gestodene

Notice details →
Belgium

Midazolam Accord Healthcare 5 mg/ml inj./inf. opl. i.m./i.v. amp. 10 x 10 ml

Nicht verfügbar · Logistics issues (transport, customs, etc.)
Active ingredient: Midazolam

Notice details →
Belgium

Mycosten 80 mg/g nagellak 3 ml

Nicht verfügbar · Sonstige
Active ingredient: Ciclopirox

Notice details →
Belgium

Pneumovax 23 inj. opl. s.c./i.m. voorgev. spuit 1 dosis (0.5 ml)

Nicht verfügbar · Increased demand
Active ingredient: Pneumococcal Polysaccharide Vaccine

Notice details →
Belgium

Sondelbay 20 µg/80 µl inj. opl. i.v. voorgev. pen 2.4 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Teriparatide

Notice details →
Belgium

Takrozem 0.1 % zalf 30 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Tacrolimus

Notice details →
Belgium

Tiberal 1 g/6 ml inf. opl. (conc.) i.v. amp. 6 ml

Nicht verfügbar · Delay in final product release
Active ingredient: Ornidazole

Notice details →
Belgium

Trabectedin Accord 0.25 mg inf. opl. (pdr., conc.) i.v. flac. 0.25 mg

Nicht verfügbar · Manufacturing delay
Active ingredient: Trabectedin

Notice details →
Belgium

Urokinase Syner-Medica 100 000 IE inj./inf. opl. (pdr.) i.v. flac. 100000 IE

Nicht verfügbar · Manufacturing delay
Active ingredient: Urokinase

Notice details →
Belgium

Valsartan Sandoz 80 mg filmomh. tabl. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Valsartan

Notice details →
Belgium

Xylocaine Spray 10 % oromucos. spray opl. spuitbus 50 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Lidocaine

Notice details →
Belgium

Zypadhera 210 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 210 mg + 3 ml

Available again · Logistics issues (transport, customs, etc.)
Active ingredient: Olanzapine

Notice details →
Belgium

Zypadhera 300 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 300 mg + 3 ml

Available again · Logistics issues (transport, customs, etc.)
Active ingredient: Olanzapine

Notice details →
Belgium

Zypadhera 405 mg inj. susp. verl. afgifte (pdr. + oplosm.) i.m. flac. 405 mg + 3 ml

Available again · Manufacturing delay
Active ingredient: Olanzapine

Notice details →
Belgium

Accofil 70 10*6 E/0.73 ml inj./inf. opl. i.v./s.c. voorgev. spuit 0.73 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Filgrastim

Notice details →
Belgium

Aciclovir Hospira 25 mg/ml inf. opl. (conc.) i.v. flac. 5 x 20 ml

Nicht verfügbar · Increased demand
Active ingredient: Aciclovir

Notice details →
Belgium

Amlor 10 mg harde caps. 100

Available again · Manufacturing delay
Active ingredient: Amlodipine

Notice details →
Belgium

Aripiprazole Mylan Pharma 10 mg tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Aripiprazole

Notice details →
Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 28 (28 x 1) UD

Nicht verfügbar · Sonstige
Active ingredient: Aripiprazole

Notice details →
Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Aripiprazole

Notice details →
Belgium

Bendamustine Accord 25 mg/ml inf. opl. (conc.) i.v. flac. 5 x 4 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Bendamustine Hydrochloride

Notice details →
Belgium

Bleomycine Hikma 15 000 IE inj. opl. (pdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. flac. 15000 IE

Nicht verfügbar · Delay in final product release
Active ingredient: Bleomycin Sulfate

Notice details →
Belgium

Diflucan 2 mg/ml inf. opl. i.v. flac. 200 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Fluconazole

Notice details →
Belgium

Emtricitabine/Tenofovir Disoproxil Mylan 200 mg - 245 mg filmomh. tabl. 30 (30 x 1) UD

Nicht verfügbar · Sonstige
Active ingredient: Emtricitabine; Tenofovir Disoproxil

Notice details →
Belgium

Epipen Junior 150 µg inj. opl. i.m. voorgev. pen 2 ml

Nicht verfügbar · Increased demand
Active ingredient: Epinephrine

Notice details →
Belgium

Feminova 50 50 µg/24 h transderm. pleister 12

Nicht verfügbar · Increased demand
Active ingredient: Estradiol hemihydrate

Notice details →
Belgium

Ferric Carboxymaltose Viatris 50 mg/ml inj./inf. disp. i.v. flac. 20 ml

Nicht verfügbar · Increased demand
Active ingredient: Iron

Notice details →
Belgium

Lipitor 20 mg filmomh. tabl. 84

Nicht verfügbar · Sonstige
Active ingredient: Atorvastatin

Notice details →
Belgium

Losartan Viatris 50 mg filmomh. tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Losartan Potassium

Notice details →
Belgium

Lyrica 300 mg harde caps. 56

Nicht verfügbar · Manufacturing delay
Active ingredient: Pregabalin

Notice details →
Belgium

Malarone 250 mg - 100 mg filmomh. tabl. 12

Nicht verfügbar · Manufacturing delay
Active ingredient: Atovaquone; Proguanil Hydrochloride

Notice details →
Belgium

Medrol 4 mg tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Methylprednisolone

Notice details →
Belgium

Metformine Viatris 850 mg filmomh. tabl. 200

Nicht verfügbar · Sonstige
Active ingredient: Metformin

Notice details →
Belgium

Myatorlip 10 mg - 10 mg filmomh. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Ezetimibe ; Atorvastatin

Notice details →
Belgium

Mycobutin 150 mg harde caps. 100

Available again · Manufacturing delay
Active ingredient: Rifabutin

Notice details →
Belgium

Nanogam 100 mg/ml inf. opl. i.v. flac. 200 ml

Available again · Sonstige
Active ingredient: Human Normal Immunoglobulin

Notice details →
Belgium

Ozalin 2 mg/ml or. opl. amp. 10 x 5 ml

Available again · In- en uitvoer vergunning in aanvraag (psychotropen, narcotica)
Active ingredient: Midazolam

Notice details →
Belgium

Prostin E2 0.5 mg tabl. 10

Nicht verfügbar · Active substance unavailable
Active ingredient: Dinoprostone

Notice details →
Belgium

Prostin E2 3 mg vagin. tabl. 4

Nicht verfügbar · Excipient unavailable
Active ingredient: Dinoprostone

Notice details →
Belgium

Rifadine 300 mg harde caps. 50

Nicht verfügbar · Increased demand
Active ingredient: Rifampicin

Notice details →
Belgium

Rivaroxaban Viatris 15 mg - 20 mg filmomh. tabl. 49 (42 (15 mg) + 7 (20 mg))

Available again · Manufacturing delay
Active ingredient: Rivaroxaban; Rivaroxaban

Notice details →
Belgium

Sertraline Viatris 100 mg filmomh. tabl. 60

Nicht verfügbar · Manufacturing delay
Active ingredient: Sertraline

Notice details →
Belgium

Systen 50 µg/24 h transderm. pleister 24

Nicht verfügbar · Increased demand
Active ingredient: Estradiol

Notice details →
Belgium

Tadalafil Mylan 20 mg filmomh. tabl. 12

Nicht verfügbar · Sonstige
Active ingredient: Tadalafil

Notice details →
Belgium

Tadalafil Mylan 20 mg filmomh. tabl. 24

Nicht verfügbar · Sonstige
Active ingredient: Tadalafil

Notice details →